Search results
RESULTS. Overall, 2084 (91%) patients developed SSc prior to age 65; whereas 216 (9%) were ≥65 years. Late-age onset patients had a significantly higher proportion of anti-centromere antibodies (42% vs 27%; p=0.001) compared to younger-age onset.
9 sty 2023 · The five-year survival rate (that is, patients who are still alive 5 years following diagnosis) among patients with diffuse cutaneous systemic sclerosis is about 84%. Five-year survival among patients with limited skin (cutaneous) systemic sclerosis is high — over 90%.
1 sty 2011 · At the Johns Hopkins Scleroderma Center, an academic specialty center, 9.5% of over 2,000 scleroderma patients in our cohort have an age of onset after 65 years. Of these patients, 69.7% have limited disease and 30.2% have diffuse disease.
11 mar 2010 · The aim of our study was to analyse the clinical characteristics of SSc patients diagnosed after the age of 65 years at our institution, and to evaluate the differences between elderly (⩾65 years) and young SSc patients related to clinical presentation and survival.
Scleroderma typically strikes between the ages of 25 and 55. In 95 percent of cases, scleroderma begins with Raynaud Phenomenon (hands and feet abnormally sensitive to cold). Federal funding for scleroderma research lags behind funding for other diseases of similar prevalence.
It is estimated that there are over 6000 people with systemic scleroderma in Australia. Statistically, approximately three to four times more women than men develop the condition. Scleroderma is found in every age group from infants to the elderly, but its onset is most frequent between the ages of 25 to 55.
Both the severity and prognosis of SSc are variable. 2 SSc more commonly develops between the ages of 30 and 50 years, and it is estimated to affect 1 in 10,000 people. 2,3. General Life Expectancy of SSc.
